Supply of medicines for multiple sclerosis Vol IX (siponimod, glatiramer acetate, interferon beta-1a (30 mcg-0.5 ml), interferon beta-1a (44 mcg-0.5 ml))

Summary

The tender concerns the supply of multiple sclerosis medicines under Vol IX in five lots (Lot-0001 to Lot-0005), including siponimod, glatiramer acetate, and interferon beta-1a (30 mcg-0.5 ml and 44 mcg-0.5 ml). The framework is 48 months long. Price is the sole award criterion. Bidders must meet the selection and compliance criteria and provide all required documents and proofs.